{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:37:16Z","timestamp":1792895836949,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,6,14]],"date-time":"2015-06-14T00:00:00Z","timestamp":1434240000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00011-015-0838-5","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T10:30:43Z","timestamp":1434191443000},"page":"603-614","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Crosstalk between peroxisome proliferator-activated receptor-\u03b3 and mineralcorticoid receptor in TNF-\u03b1 activated renal tubular cell"],"prefix":"10.1007","volume":"64","author":[{"given":"Jing","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chensheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,14]]},"reference":[{"key":"838_CR1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000063558","volume":"20","author":"B Descamps-Latscha","year":"2002","unstructured":"Descamps-Latscha B, Jungers P, Witko-Sarsat V. Immune system dysregulation in uremia: role of oxidative stress. Blood Purif. 2002;20:481\u20134.","journal-title":"Blood Purif"},{"key":"838_CR2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1525-139X.2007.00283.x","volume":"20","author":"T Eleftheriadis","year":"2007","unstructured":"Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I. Disturbances of acquired immunity in hemodialysis patients. Semin Dial. 2007;20:440\u201351.","journal-title":"Semin Dial"},{"key":"838_CR3","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.00950208","volume":"3","author":"S Kato","year":"2008","unstructured":"Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008;3:1526\u201333.","journal-title":"Clin J Am Soc Nephrol"},{"key":"838_CR4","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.2741\/3467","volume":"14","author":"G Rangan","year":"2009","unstructured":"Rangan G, Wang Y, Harris D. NF-kappaB signalling in chronic kidney disease. Front Biosci (Landmark Ed). 2009;14:3496\u2013522.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"838_CR5","doi-asserted-by":"crossref","first-page":"900","DOI":"10.5301\/jn.5000134","volume":"25","author":"L Tylicki","year":"2012","unstructured":"Tylicki L, Lizakowski S, Rutkowski B. Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions. J Nephrol. 2012;25:900\u201310.","journal-title":"J Nephrol"},{"key":"838_CR6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10157-011-0498-x","volume":"16","author":"Y Terada","year":"2012","unstructured":"Terada Y, Ueda S, Hamada K, Shimamura Y, Ogata K, Inoue K, et al. Aldosterone stimulates nuclear factor-kappa B activity and transcription of intercellular adhesion molecule-1 and connective tissue growth factor in rat mesangial cells via serum- and glucocorticoid-inducible protein kinase-1. Clin Exp Nephrol. 2012;16:81\u20138.","journal-title":"Clin Exp Nephrol"},{"key":"838_CR7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/ndt\/gfs429","volume":"28","author":"E Morales","year":"2013","unstructured":"Morales E, Millet VG, Rojas-Rivera J, Huerta A, Gutierrez E, Gutierrez-Solis E, et al. Renoprotective effects of mineralocorticoid receptor blockers in patients with proteinuric kidney diseases. Nephrol Dial Transplant. 2013;28:405\u201312.","journal-title":"Nephrol Dial Transplant"},{"key":"838_CR8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/1470320312443911","volume":"13","author":"M Bayorh","year":"2012","unstructured":"Bayorh M, Rollins-Hairston A, Adiyiah J, Lyn D, Eatman D. Eplerenone inhibits aldosterone-induced renal expression of cyclooxygenase. J Renin Angiotensin Aldosterone Syst. 2012;13:353\u20139.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"838_CR9","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3109\/0886022X.2012.672156","volume":"34","author":"TK Ma","year":"2012","unstructured":"Ma TK, Szeto CC. Mineralocorticoid receptor antagonist for renal protection. Ren Fail. 2012;34:810\u20137.","journal-title":"Ren Fail"},{"key":"838_CR10","first-page":"606","volume":"4","author":"E Zitt","year":"2011","unstructured":"Zitt E, Eller K, Huber JM, Kirsch AH, Tagwerker A, Mayer G, et al. The selective mineralocorticoid receptor antagonist eplerenone is protective in mild anti-GBM glomerulonephritis. Int J Clin Exp Pathol. 2011;4:606\u201315.","journal-title":"Int J Clin Exp Pathol"},{"key":"838_CR11","doi-asserted-by":"crossref","first-page":"e39938","DOI":"10.1371\/journal.pone.0039938","volume":"7","author":"NF Banki","year":"2012","unstructured":"Banki NF, Ver A, Wagner LJ, Vannay A, Degrell P, Prokai A, et al. Aldosterone antagonists in monotherapy are protective against streptozotocin-induced diabetic nephropathy in rats. PLoS One. 2012;7:e39938.","journal-title":"PLoS One"},{"key":"838_CR12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4093\/dmj.2012.36.2.128","volume":"36","author":"JH Ahn","year":"2012","unstructured":"Ahn JH, Hong HC, Cho MJ, Kim YJ, Choi HY, Eun CR, et al. Effect of eplerenone, a selective aldosterone blocker, on the development of diabetic nephropathy in type 2 diabetic rats. Diabetes Metab J. 2012;36:128\u201335.","journal-title":"Diabetes Metab J"},{"key":"838_CR13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2174\/1874467211205020248","volume":"5","author":"A Sugawara","year":"2012","unstructured":"Sugawara A, Uruno A, Matsuda K, Saito-Ito T, Funato T, Saito-Hakoda A, et al. Effects of PPARgamma agonists against vascular and renal dysfunction. Curr Mol Pharmacol. 2012;5:248\u201354.","journal-title":"Curr Mol Pharmacol"},{"key":"838_CR14","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/ndt\/gfn746","volume":"24","author":"J Xiao","year":"2009","unstructured":"Xiao J, Leung JC, Chan LY, Guo H, Lai KN. Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy. Nephrol Dial Transplant. 2009;24:2067\u201377.","journal-title":"Nephrol Dial Transplant"},{"key":"838_CR15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.clim.2009.04.004","volume":"132","author":"J Xiao","year":"2009","unstructured":"Xiao J, Leung JC, Chan LY, Tang SC, Lai KN. Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy. Clin Immunol. 2009;132:266\u201376.","journal-title":"Clin Immunol"},{"key":"838_CR16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/ndt\/gfm581","volume":"23","author":"JC Leung","year":"2008","unstructured":"Leung JC, Tang SC, Chan LY, Chan WL, Lai KN. Synthesis of TNF-alpha by mesangial cells cultured with polymeric anionic IgA\u2013role of MAPK and NF-kappaB. Nephrol Dial Transplant. 2008;23:72\u201381.","journal-title":"Nephrol Dial Transplant"},{"key":"838_CR17","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ki.2009.142","volume":"76","author":"T Ernandez","year":"2009","unstructured":"Ernandez T, Mayadas TN. Immunoregulatory role of TNFalpha in inflammatory kidney diseases. Kidney Int. 2009;76:262\u201376.","journal-title":"Kidney Int"},{"key":"838_CR18","first-page":"2111","volume":"7","author":"DI Vazquez-Huerta","year":"2014","unstructured":"Vazquez-Huerta DI, Alvarez-Rodriguez BA, Topete-Reyes JF, Munoz-Valle JF, Parra-Michel R, Fuentes-Ramirez F, et al. Tumor necrosis factor alpha \u2212238 G\/A and \u2212308 G\/A polymorphisms and soluble TNF-alpha levels in chronic kidney disease: correlation with clinical variables. Int J Clin Exp Med. 2014;7:2111\u20139.","journal-title":"Int J Clin Exp Med"},{"key":"838_CR19","doi-asserted-by":"crossref","first-page":"F945","DOI":"10.1152\/ajprenal.00423.2007","volume":"294","author":"KN Lai","year":"2008","unstructured":"Lai KN, Leung JC, Chan LY, Saleem MA, Mathieson PW, Lai FM, et al. Activation of podocytes by mesangial-derived TNF-alpha: glomerulo-podocytic communication in IgA nephropathy. Am J Physiol Renal Physiol. 2008;294:F945\u201355.","journal-title":"Am J Physiol Renal Physiol"},{"key":"838_CR20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000340033","volume":"36","author":"FJ Therrien","year":"2012","unstructured":"Therrien FJ, Agharazii M, Lebel M, Lariviere R. Neutralization of tumor necrosis factor-alpha reduces renal fibrosis and hypertension in rats with renal failure. Am J Nephrol. 2012;36:151\u201361.","journal-title":"Am J Nephrol"},{"key":"838_CR21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.steroids.2013.10.016","volume":"81","author":"M Gekle","year":"2014","unstructured":"Gekle M, Bretschneider M, Meinel S, Ruhs S, Grossmann C. Rapid mineralocorticoid receptor trafficking. Steroids. 2014;81:103\u20138.","journal-title":"Steroids"},{"key":"838_CR22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-0031-1295461","volume":"44","author":"VG Fourkiotis","year":"2012","unstructured":"Fourkiotis VG, Hanslik G, Hanusch F, Lepenies J, Quinkler M. Aldosterone and the kidney. Horm Metab Res. 2012;44:194\u2013201.","journal-title":"Horm Metab Res"},{"key":"838_CR23","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/ki.2012.170","volume":"82","author":"JM Luther","year":"2012","unstructured":"Luther JM, Luo P, Wang Z, Cohen SE, Kim HS, Fogo AB, et al. Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury. Kidney Int. 2012;82:643\u201351.","journal-title":"Kidney Int"},{"key":"838_CR24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijcard.2013.06.046","volume":"169","author":"CF Tsai","year":"2013","unstructured":"Tsai CF, Yang SF, Chu HJ, Ueng KC. Cross-talk between mineralocorticoid receptor\/angiotensin II type 1 receptor and mitogen-activated protein kinase pathways underlies aldosterone-induced atrial fibrotic responses in HL-1 cardiomyocytes. Int J Cardiol. 2013;169:17\u201328.","journal-title":"Int J Cardiol"},{"key":"838_CR25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jsbmb.2007.03.043","volume":"107","author":"V McEneaney","year":"2007","unstructured":"McEneaney V, Harvey BJ, Thomas W. Aldosterone rapidly activates protein kinase D via a mineralocorticoid receptor\/EGFR trans-activation pathway in the M1 kidney CCD cell line. J Steroid Biochem Mol Biol. 2007;107:180\u201390.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"838_CR26","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2337\/db07-1241","volume":"57","author":"V Kolavennu","year":"2008","unstructured":"Kolavennu V, Zeng L, Peng H, Wang Y, Danesh FR. Targeting of RhoA\/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control. Diabetes. 2008;57:714\u201323.","journal-title":"Diabetes"},{"key":"838_CR27","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/cvr\/cvr131","volume":"91","author":"GE Callera","year":"2011","unstructured":"Callera GE, Yogi A, Briones AM, Montezano AC, He Y, Tostes RC, et al. Vascular proinflammatory responses by aldosterone are mediated via c-Src trafficking to cholesterol-rich microdomains: role of PDGFR. Cardiovasc Res. 2011;91:720\u201331.","journal-title":"Cardiovasc Res"},{"key":"838_CR28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jsbmb.2011.12.014","volume":"129","author":"M Fujii","year":"2012","unstructured":"Fujii M, Inoki I, Saga M, Morikawa N, Arakawa K, Inaba S, et al. Aldosterone inhibits endothelial morphogenesis and angiogenesis through the downregulation of vascular endothelial growth factor receptor-2 expression subsequent to peroxisome proliferator-activated receptor gamma. J Steroid Biochem Mol Biol. 2012;129:145\u201352.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"838_CR29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/MNH.0b013e32834de526","volume":"21","author":"J Yang","year":"2012","unstructured":"Yang J, Zhou Y, Guan Y. PPARgamma as a therapeutic target in diabetic nephropathy and other renal diseases. Curr Opin Nephrol Hypertens. 2012;21:97\u2013105.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"838_CR30","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/ndt\/gfl766","volume":"22","author":"X Li","year":"2007","unstructured":"Li X, Kimura H, Hirota K, Sugimoto H, Kimura N, Takahashi N, et al. Hypoxia reduces the expression and anti-inflammatory effects of peroxisome proliferator-activated receptor-gamma in human proximal renal tubular cells. Nephrol Dial Transplant. 2007;22:1041\u201351.","journal-title":"Nephrol Dial Transplant"},{"key":"838_CR31","doi-asserted-by":"crossref","first-page":"29981","DOI":"10.1074\/jbc.M110.110908","volume":"285","author":"X Wen","year":"2010","unstructured":"Wen X, Li Y, Liu Y. Opposite action of peroxisome proliferator-activated receptor-gamma in regulating renal inflammation: functional switch by its ligand. J Biol Chem. 2010;285:29981\u20138.","journal-title":"J Biol Chem"},{"key":"838_CR32","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","volume":"117","author":"C Guo","year":"2008","unstructured":"Guo C, Ricchiuti V, Lian BQ, Yao TM, Coutinho P, Romero JR, et al. Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines. Circulation. 2008;117:2253\u201361.","journal-title":"Circulation"},{"key":"838_CR33","first-page":"87","volume":"62","author":"M Miana","year":"2011","unstructured":"Miana M, de Las Heras N, Rodriguez C, Sanz-Rosa D, Martin-Fernandez B, Mezzano S, et al. Effect of eplerenone on hypertension-associated renal damage in rats: potential role of peroxisome proliferator activated receptor gamma (PPAR-gamma). J Physiol Pharmacol. 2011;62:87\u201394.","journal-title":"J Physiol Pharmacol"},{"key":"838_CR34","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1536\/ihj.48.637","volume":"48","author":"T Takahashi","year":"2007","unstructured":"Takahashi T, Ono H, Ono Y, Ishimitsu T, Matsuoka H. Combination therapy with telmisartan and spironolactone alleviates L-NAME exacerbated nephrosclerosis with an increase in PPAR-gamma and decrease in TGF-beta(1). Int Heart J. 2007;48:637\u201347.","journal-title":"Int Heart J"},{"key":"838_CR35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1677\/JME-10-0088","volume":"46","author":"A Uruno","year":"2011","unstructured":"Uruno A, Matsuda K, Noguchi N, Yoshikawa T, Kudo M, Satoh F, et al. Peroxisome proliferator-activated receptor-{gamma} suppresses CYP11B2 expression and aldosterone production. J Mol Endocrinol. 2011;46:37\u201349.","journal-title":"J Mol Endocrinol"},{"key":"838_CR36","doi-asserted-by":"crossref","first-page":"F393","DOI":"10.1152\/ajprenal.00418.2010","volume":"300","author":"Y Yuan","year":"2011","unstructured":"Yuan Y, Zhang A, Huang S, Ding G, Chen R. A PPARgamma agonist inhibits aldosterone-induced mesangial cell proliferation by blocking ROS-dependent EGFR intracellular signaling. Am J Physiol Renal Physiol. 2011;300:F393\u2013402.","journal-title":"Am J Physiol Renal Physiol"},{"key":"838_CR37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1042\/CS20130412","volume":"127","author":"M Alique","year":"2014","unstructured":"Alique M, Civantos E, Sanchez-Lopez E, Lavoz C, Rayego-Mateos S, Rodrigues-Diez R, et al. Integrin-linked kinase plays a key role in the regulation of angiotensin II-induced renal inflammation. Clin Sci (Lond). 2014;127:19\u201331.","journal-title":"Clin Sci (Lond)"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-015-0838-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00011-015-0838-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-015-0838-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T13:47:53Z","timestamp":1558532873000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00011-015-0838-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,14]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["838"],"URL":"https:\/\/doi.org\/10.1007\/s00011-015-0838-5","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,14]]}}}